Profile - To The Moon

xDevilSMx

Posts · 17Posts · 17
Following · 0Following · 0
Followers · 0Followers · 0

- xDevilSMxxDevilSMx
  ·2022-01-05
  drop so much
  3 Reasons to Buy Snowflake, and 1 Reason to Sell
  Is this cloud data platform the best cloud stock to buy right now?
  3 Reasons to Buy Snowflake, and 1 Reason to Sell
  2.37K Comment
  1
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-07-13
  $AMC Entertainment(AMC)$lets sign petition for AMC http://chng.it/V2RMQYMhw8
  2.70K 1
  4
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-07-12
  Bruh! No.3 AMC literally jump from $10+ to $72 this year, and it jump from $40+ to 60+ afterwards. And you say it has fail track record and only 20% rise? What world you live in or what drug did you took?
  Sorry, this post has been deleted
  2.65K 1
  10
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-06-23
  Nani?
  2.01K Comment
  Like
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-06-23
  $Presidio Property Trust(SQFT)$ok
  2.69K Comment
  Like
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-06-23
  $Workhorse(WKHS)$hitting 16?
  1.63K Comment
  1
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-06-16
  $ContextLogic Inc.(WISH)$chance to go back $20?
  4.20K 5
  4
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-06-16
  $Torchlight Energy Resources(TRCH)$is it a good time to join?
  3.75K 2
  1
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-06-15
  $AMC Entertainment(AMC)$lets go bois!
  2.90K 1
  4
  Share
  Report
- xDevilSMxxDevilSMx
  ·2021-06-15
  No money to buy this stock =(
  Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
  Ocugen, Inc.(NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and comm
  Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™
  2.09K Comment
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3584927110529396","uuid":"3584927110529396","gmtCreate":1621833087214,"gmtModify":1704447501806,"name":"xDevilSMx","pinyin":"xdevilsmx","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":18,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"93.08%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.29%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9001735949,"gmtCreate":1641315689270,"gmtModify":1676533597090,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"drop so much","listText":"drop so much","text":"drop so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001735949","repostId":"2200404582","repostType":4,"repost":{"id":"2200404582","kind":"highlight","pubTimestamp":1641308662,"share":"https://ttm.financial/m/news/2200404582?lang=&edition=fundamental","pubTime":"2022-01-04 23:04","market":"us","language":"en","title":"3 Reasons to Buy Snowflake, and 1 Reason to Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2200404582","media":"Motley Fool","summary":"Is this cloud data platform the best cloud stock to buy right now?","content":"<div>\n<p>Snowflake's (NYSE:SNOW) cloud platform is experiencing tremendous demand as businesses continue to rely more on cloud services to process and store data. Cloud infrastructure spending grew 37% year ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-reasons-to-buy-snowflake-and-1-reason-to-sell/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Reasons to Buy Snowflake, and 1 Reason to Sell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Reasons to Buy Snowflake, and 1 Reason to Sell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 23:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/04/3-reasons-to-buy-snowflake-and-1-reason-to-sell/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Snowflake's (NYSE:SNOW) cloud platform is experiencing tremendous demand as businesses continue to rely more on cloud services to process and store data. Cloud infrastructure spending grew 37% year ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-reasons-to-buy-snowflake-and-1-reason-to-sell/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4548":"巴美列捷福持仓","BK4535":"淡马锡持仓","BK4505":"高瓴资本持仓","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4503":"景林资产持仓","SNOW":"Snowflake","BK4559":"巴菲特持仓","BK4551":"寇图资本持仓","BK4116":"互联网服务与基础架构"},"source_url":"https://www.fool.com/investing/2022/01/04/3-reasons-to-buy-snowflake-and-1-reason-to-sell/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200404582","content_text":"Snowflake's (NYSE:SNOW) cloud platform is experiencing tremendous demand as businesses continue to rely more on cloud services to process and store data. Cloud infrastructure spending grew 37% year over year in the third quarter, with services from Amazon, Microsoft, and Alphabet's Google controlling 63% of the market. That's good news for Snowflake since its cloud-based data warehousing system is compatible with these cloud services. Snowflake is piggybacking the growth of the market.Some of the largest companies in the world use Snowflake to organize, share data, and gather insights to optimize their operations. Let's look at three reasons to buy the stock before considering why investors might want to take a pass.1. Snowflake is reaching critical massSnowflake offers several features, including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. There are many reasons that a company would choose Snowflake, but a few key benefits are ease of use, good security features, and a consumption-based business model that only charges customers for what they use.A previous story from Harvard Business Review explained how Kraft Heinz benefited after moving half a trillion records over to Snowflake's platform through Microsoft Azure. Since making that move, Kraft Heinz has been able to better understand its supply chain to get the right inventory to supermarkets during the pandemic.Nearly half of the Fortune 500 uses Snowflake. Since its initial public offering in September 2020, Snowflake has posted revenue growth rates above 100% every quarter. While past performance shouldn't be used to predict future growth, the business has a lot of upside. Management previously estimated the long-term addressable market at $81 billion as of January 2020. That's massive compared to its trailing-12-month revenue total of $1 billion.2. A widening competitive moatOne risk to Snowflake's growth is that it competes with Amazon Web Services and other top cloud providers that offer similar solutions. But one way Snowflake separates itself is by enabling expanding use cases on the platform through data sharing.For example, Snowflake's data marketplace allows advertising and media companies to access viewership data across hundreds of sources without having to build costly data pipelines. By simply joining Snowflake's platform, companies can exchange and share data with other Snowflake clients, which is enormously valuable.Data sharing gives Snowflake a network effect competitive advantage. The more businesses join the platform, the more data other customers can access, which increases the value for all customers. Eight new Fortune 500 companies joined Snowflake in its Q3 -- a sign its competitive moat just got a little wider.3. Management's long-term outlookSnowflake's growing network effect should lead to another competitive advantage -- switching costs. As it builds a greater marketplace of shared data, it incentivizes companies to stick with Snowflake because switching to another platform would mean losing access to data that wouldn't be available elsewhere.A growing market coupled with Snowflake's strengths explains why management sees a path to reach $10 billion in product revenue by fiscal 2029 (which ends in January). That translates to an annualized growth rate of about 39% from calendar 2021. Management believes revenue can still grow at 30% per year beyond fiscal 2029, with the business generating a 15% free cash flow margin.Beware of Snowflake's high price tagBased on management's long-term target, Snowflake should be generating $1.5 billion in free cash flow by fiscal 2029. It seems investors are banking on that outlook, and then some.Snowflake's current market cap (total shares outstanding times the stock price) is $101 billion. That is 67 times what management believes free cash flow will be in seven years.To understand how expensive that is, let's compare Snowflake's valuation to another top cloud provider, Alphabet. Google's parent company just posted revenue growth of 41% year over year in Q3, but its share price trades at 30 times trailing-12-month free cash flow.Even the high-flying chipmaker Nvidia, which sells graphics processors to the top cloud providers, trades at 107 times trailing free cash flow. I would rather pay a high multiple for free cash flow already booked than pay a high valuation for a future promise that is years away.Ultimately, valuation matters. Snowflake is a promising investment opportunity, but investors should consider other software stocks that offer better value before buying shares of Snowflake.","news_type":1,"symbols_score_info":{"SNOW":1}},"isVote":1,"tweetType":1,"viewCount":2370,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142480811,"gmtCreate":1626167971033,"gmtModify":1703754694613,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>lets sign petition for AMC http://chng.it/V2RMQYMhw8","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>lets sign petition for AMC http://chng.it/V2RMQYMhw8","text":"$AMC Entertainment(AMC)$lets sign petition for AMC http://chng.it/V2RMQYMhw8","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/142480811","isVote":1,"tweetType":1,"viewCount":2701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146726947,"gmtCreate":1626100210289,"gmtModify":1703753441311,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"Bruh! No.3 AMC literally jump from $10+ to $72 this year, and it jump from $40+ to 60+ afterwards. And you say it has fail track record and only 20% rise? What world you live in or what drug did you took?","listText":"Bruh! No.3 AMC literally jump from $10+ to $72 this year, and it jump from $40+ to 60+ afterwards. And you say it has fail track record and only 20% rise? What world you live in or what drug did you took?","text":"Bruh! No.3 AMC literally jump from $10+ to $72 this year, and it jump from $40+ to 60+ afterwards. And you say it has fail track record and only 20% rise? What world you live in or what drug did you took?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/146726947","repostId":"2150580297","repostType":4,"isVote":1,"tweetType":1,"viewCount":2654,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121675410,"gmtCreate":1624463939230,"gmtModify":1703837639562,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"Nani?","listText":"Nani?","text":"Nani?","images":[{"img":"https://static.tigerbbs.com/9c8927ed94f8a1b462dc48db349d84f8","width":"720","height":"2154"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121675410","isVote":1,"tweetType":1,"viewCount":2010,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121673910,"gmtCreate":1624463714130,"gmtModify":1703837630011,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SQFT\">$Presidio Property Trust(SQFT)$</a>ok","listText":"<a href=\"https://laohu8.com/S/SQFT\">$Presidio Property Trust(SQFT)$</a>ok","text":"$Presidio Property Trust(SQFT)$ok","images":[{"img":"https://static.tigerbbs.com/1caf30909dc6d931914701b9dad1e7ef","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121673910","isVote":1,"tweetType":1,"viewCount":2692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121663081,"gmtCreate":1624462150143,"gmtModify":1703837573433,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WKHS\">$Workhorse(WKHS)$</a>hitting 16?","listText":"<a href=\"https://laohu8.com/S/WKHS\">$Workhorse(WKHS)$</a>hitting 16?","text":"$Workhorse(WKHS)$hitting 16?","images":[{"img":"https://static.tigerbbs.com/d338f9f220f3fae5a98fa8c89f4c9d43","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121663081","isVote":1,"tweetType":1,"viewCount":1630,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":163989879,"gmtCreate":1623856637391,"gmtModify":1703821649328,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>chance to go back $20?","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>chance to go back $20?","text":"$ContextLogic Inc.(WISH)$chance to go back $20?","images":[{"img":"https://static.tigerbbs.com/3776a2112bd7cddd40282adf91ee02cd","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/163989879","isVote":1,"tweetType":1,"viewCount":4203,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3582674937202951","authorId":"3582674937202951","name":"买啥啥跌啥","avatar":"https://static.tigerbbs.com/a527f9e576b96fe9d639741ef2b5b720","crmLevel":11,"crmLevelSwitch":1,"idStr":"3582674937202951","authorIdStr":"3582674937202951"},"content":"You wait long long hahaha","text":"You wait long long hahaha","html":"You wait long long hahaha"},{"author":{"id":"3580712608470960","authorId":"3580712608470960","name":"TradeMaster","avatar":"https://static.tigerbbs.com/6d65e96d9a79be6c91187ea27f924d3a","crmLevel":12,"crmLevelSwitch":0,"idStr":"3580712608470960","authorIdStr":"3580712608470960"},"content":"Long term yes...","text":"Long term yes...","html":"Long term yes..."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":169699440,"gmtCreate":1623831473980,"gmtModify":1703820772701,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TRCH\">$Torchlight Energy Resources(TRCH)$</a>is it a good time to join?","listText":"<a href=\"https://laohu8.com/S/TRCH\">$Torchlight Energy Resources(TRCH)$</a>is it a good time to join?","text":"$Torchlight Energy Resources(TRCH)$is it a good time to join?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/169699440","isVote":1,"tweetType":1,"viewCount":3751,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187583943,"gmtCreate":1623758934282,"gmtModify":1703818336486,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>lets go bois!","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>lets go bois!","text":"$AMC Entertainment(AMC)$lets go bois!","images":[{"img":"https://static.tigerbbs.com/d0f43af046651755b722c03d36a1642c","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/187583943","isVote":1,"tweetType":1,"viewCount":2898,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":187589822,"gmtCreate":1623758902966,"gmtModify":1703818335297,"author":{"id":"3584927110529396","authorId":"3584927110529396","name":"xDevilSMx","avatar":"https://static.tigerbbs.com/4365972c2b5adedf9684867e4050f6a9","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584927110529396","authorIdStr":"3584927110529396"},"themes":[],"htmlText":"No money to buy this stock =(","listText":"No money to buy this stock =(","text":"No money to buy this stock =(","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187589822","repostId":"1178091722","repostType":4,"repost":{"id":"1178091722","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623757022,"share":"https://ttm.financial/m/news/1178091722?lang=&edition=fundamental","pubTime":"2021-06-15 19:37","market":"us","language":"en","title":"Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™","url":"https://stock-news.laohu8.com/highlight/detail?id=1178091722","media":"Tiger Newspress","summary":"Ocugen, Inc.(NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and comm","content":"<p></p>\n<p><img src=\"https://static.tigerbbs.com/30195a620eedea62e516df9d39d4d93b\" tg-width=\"663\" tg-height=\"440\">Ocugen, Inc.(NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner forCOVAXIN™to prepare for potential commercial manufacturing of COVAXIN™ for the US and Canadian markets.</p>\n<p>“We are fully committed to bringing COVAXIN to the US and Canadian markets because we believe it has the potential to save lives by adding a weapon to the arsenal in the fight against emerging variants,” saidJ.P. Gabriel, Ocugen’s Senior Vice President, Manufacturing and Supply Chain. “Securing US-based manufacturing capability is a critical step as we prepare to submit our regulatory submissions to the FDA and Health Canada. Based on Bharat Biotech’s strong track record of developing and commercializing vaccines globally and Jubilant’s proven track record in manufacturing, we are well-prepared to transition US manufacturing of COVAXIN to our new partner.”</p>\n<p>“We are excited to expand our basket of vaccine products and meet the increasing demand from our customers for COVID-19 vaccines in the US,” said Amit Arora, President Jubilant HollisterStier.</p>\n<p>“We are pleased to partner with Ocugen and support the ongoing fight against COVID-19. With two facilities in North America working to manufacture multiple COVID-19 vaccines and therapies, we remain committed to supporting efforts to eradicate this global pandemic,” stated Pramod Yadav, CEO Jubilant Pharma Limited.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-15 19:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p></p>\n<p><img src=\"https://static.tigerbbs.com/30195a620eedea62e516df9d39d4d93b\" tg-width=\"663\" tg-height=\"440\">Ocugen, Inc.(NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner forCOVAXIN™to prepare for potential commercial manufacturing of COVAXIN™ for the US and Canadian markets.</p>\n<p>“We are fully committed to bringing COVAXIN to the US and Canadian markets because we believe it has the potential to save lives by adding a weapon to the arsenal in the fight against emerging variants,” saidJ.P. Gabriel, Ocugen’s Senior Vice President, Manufacturing and Supply Chain. “Securing US-based manufacturing capability is a critical step as we prepare to submit our regulatory submissions to the FDA and Health Canada. Based on Bharat Biotech’s strong track record of developing and commercializing vaccines globally and Jubilant’s proven track record in manufacturing, we are well-prepared to transition US manufacturing of COVAXIN to our new partner.”</p>\n<p>“We are excited to expand our basket of vaccine products and meet the increasing demand from our customers for COVID-19 vaccines in the US,” said Amit Arora, President Jubilant HollisterStier.</p>\n<p>“We are pleased to partner with Ocugen and support the ongoing fight against COVID-19. With two facilities in North America working to manufacture multiple COVID-19 vaccines and therapies, we remain committed to supporting efforts to eradicate this global pandemic,” stated Pramod Yadav, CEO Jubilant Pharma Limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178091722","content_text":"Ocugen, Inc.(NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner forCOVAXIN™to prepare for potential commercial manufacturing of COVAXIN™ for the US and Canadian markets.\n“We are fully committed to bringing COVAXIN to the US and Canadian markets because we believe it has the potential to save lives by adding a weapon to the arsenal in the fight against emerging variants,” saidJ.P. Gabriel, Ocugen’s Senior Vice President, Manufacturing and Supply Chain. “Securing US-based manufacturing capability is a critical step as we prepare to submit our regulatory submissions to the FDA and Health Canada. Based on Bharat Biotech’s strong track record of developing and commercializing vaccines globally and Jubilant’s proven track record in manufacturing, we are well-prepared to transition US manufacturing of COVAXIN to our new partner.”\n“We are excited to expand our basket of vaccine products and meet the increasing demand from our customers for COVID-19 vaccines in the US,” said Amit Arora, President Jubilant HollisterStier.\n“We are pleased to partner with Ocugen and support the ongoing fight against COVID-19. With two facilities in North America working to manufacture multiple COVID-19 vaccines and therapies, we remain committed to supporting efforts to eradicate this global pandemic,” stated Pramod Yadav, CEO Jubilant Pharma Limited.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2087,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}